Myc interacts genetically with Tip48/Reptin and Tip49/Pontin to control growth and proliferation during Drosophila development. by Bellosta, P et al.
University of Zurich





Myc interacts genetically with Tip48/Reptin and Tip49/Pontin to
control growth and proliferation during Drosophila development
Bellosta, Paola; Hulf, Toby; Balla Diop, Soda; Usseglio, Fabrice; Pradel, Jacques;
Aragnol, Denise; Gallant, Peter
Bellosta, Paola; Hulf, Toby; Balla Diop, Soda; Usseglio, Fabrice; Pradel, Jacques; Aragnol, Denise; Gallant, Peter.
Myc interacts genetically with Tip48/Reptin and Tip49/Pontin to control growth and proliferation during
Drosophila development. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(33):11799-804.
Postprint available at:
http://www.zora.unizh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.unizh.ch
Originally published at:
Proc. Natl. Acad. Sci. U.S.A. 2005, 102(33):11799-804
Bellosta, Paola; Hulf, Toby; Balla Diop, Soda; Usseglio, Fabrice; Pradel, Jacques; Aragnol, Denise; Gallant, Peter.
Myc interacts genetically with Tip48/Reptin and Tip49/Pontin to control growth and proliferation during
Drosophila development. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(33):11799-804.
Postprint available at:
http://www.zora.unizh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.unizh.ch
Originally published at:
Proc. Natl. Acad. Sci. U.S.A. 2005, 102(33):11799-804
Myc interacts genetically with Tip48/Reptin and Tip49/Pontin to
control growth and proliferation during Drosophila development
Abstract
The transcription factor dMyc is the sole Drosophila ortholog of the vertebrate c-myc protooncogenes
and a central regulator of growth and cell-cycle progression during normal development. We have
investigated the molecular basis of dMyc function by analyzing its interaction with the putative
transcriptional cofactors Tip48/Reptin (Rept) and Tip49/Pontin (Pont). We demonstrate that Rept and
Pont have conserved their ability to bind to Myc during evolution. All three proteins are required for
tissue growth in vivo, because mitotic clones mutant for either dmyc, pont,or rept suffer from cell
competition. Most importantly, pont shows a strong dominant genetic interaction with dmyc that is
manifested in the duration of development, rates of survival and size of the adult animal and, in
particular, of the eye. The molecular basis for these effects may be found in the repression of certain
target genes, such as mfas, by dMyc:Pont complexes. These findings indicate that dMyc:Pont complexes
play an essential role in the control of cellular growth and proliferation during normal development.
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The transcription factor dMyc is the soleDrosophila ortholog of the
vertebrate c-myc protooncogenes and a central regulator of
growth and cell-cycle progression during normal development. We
have investigated the molecular basis of dMyc function by ana-
lyzing its interaction with the putative transcriptional cofactors
Tip48Reptin (Rept) and Tip49Pontin (Pont). We demonstrate that
Rept and Pont have conserved their ability to bind to Myc during
evolution. All three proteins are required for tissue growth in vivo,
because mitotic clones mutant for either dmyc, pont, or rept suffer
from cell competition. Most importantly, pont shows a strong
dominant genetic interaction with dmyc that is manifested in the
duration of development, rates of survival and size of the adult
animal and, in particular, of the eye. The molecular basis for these
effects may be found in the repression of certain target genes, such
as mfas, by dMyc:Pont complexes. These findings indicate that
dMyc:Pont complexes play an essential role in the control of
cellular growth and proliferation during normal development.
repression  transcription
Myc proteins are essential regulators of growth, proliferation,and apoptosis in metazoans (1–3). These proteins act as
transcription factors to control the expression of numerous target
genes involved in growth, metabolism, and other processes (4–7).
Less is known about the molecular mechanism that allows Myc to
control the expression of these targets. In recent years, different
modes of gene activation by Myc have been proposed, notably
recruitment of chromatin remodelers (8), histone acetylases (e.g.,
ref. 9), or RNA pol II kinases (10), but the physiological relevance
of these different factors for Myc-dependent biological functions
needs to be demonstrated. We therefore set out to study the
mechanisms of Myc-controlled growth and proliferation during
normal development by using Drosophila as a model system.
Initially, we focused on the interaction of Myc with two specific
components of cofactor complexes, Tip48 andTip49, because of the
availability of null mutations in the corresponding genes [called
reptin (rept) and pontin (pont) in flies, respectively].
Tip48 and Tip49 are closely related proteins that show a high
similarity to the bacterial ATP-dependent AAA super family
DNA helicase RuvB. Orthologs of Tip48 and Tip49 have been
identified in plants, yeast, and animals (e.g., refs. 11 and 12).
Different observations strongly suggest that one major function of
the Tip proteins resides in the control of transcription. Initially,
vertebrate Tip49was found to be aTata-binding protein-interacting
protein (13–16); later Tip48 and Tip49 were also shown to interact
physically with the different transcription factors -catenin (11, 14),
c-Myc (12), E2F1 (only Tip49) (17), and ATF2 (only Tip48) (18),
raising the possibility that the Tip proteins could bridge basic
transcription machinery and sequence-specific activators. Both
proteins were also purified as part of several multiprotein com-
plexes involved in transcriptional regulation: the Ino80 chromatin
remodeling complex in yeast (19, 20), Polycomb repressive complex
1 in Drosophila (only Tip48) (21), the Tip60 HAT complex in
vertebrates (22), and the Uri complex regulating nutrition-
dependent gene expression in yeast and in vertebrates (23). Inter-
estingly, three other proteins that were found to bind the N
terminus of c-Myc share residence with Tip48 and Tip49 in the
Ino80 (BAF53 and -actin) (24) or Tip60 complex (transforma-
tiontranscription-domain-associated protein, BAF53, and -actin)
(24, 25). Further support for an involvement of Tip48 and Tip49 in
transcription is provided by the observations that both proteins
colocalize with c-Myc on the nucleolin promoter (26) and that
elimination of Tip48 or Tip49 function in yeast rapidly affects the
expression of a large number of targets (16, 27, 28). Such a
transcriptional role is also consistent with the described genetic
interactions between a tip48 mutation and -catenin in zebrafish
and interactions of tip48 and tip49 with a -catenin-reporter system
in Drosophila (11, 29); in both of these in vivo interactions, Tip48
behaved as a negative component and Tip49 behaved as a positive
component of theWg signaling cascade. Similar opposing activities
were also documented in a human cell line by assaying the ability
of the -catenin–T cell factor complex to activate a reporter gene
(11). A potential role for Tip49 in Myc-dependent functions was
addressed in a recent study that examined the consequences of
coexpressing wild-type or putative dominant-negative forms of
Tip49 with c-Myc. Neither form had any effect on control cells, but
both enhanced the apoptosis caused by overexpressed c-Myc, and
they reduced the ability of c-Myc in combination with activatedRas
to transform rat embryo fibroblasts, which indicates that, upon
forced overexpression, Myc might require Tip49 activity (17).
In the present study we show that the physical interaction
betweenMyc andPontRept is conserved in flies, that pontrept are
essential for tissue growth in vivo, and that dmyc and pont show a
strong genetic interaction. We further identify the gene mfas as a
transcriptional target that is repressed by dMyc:Pont complexes.
These studies provide the first evidence that Pont and Rept are
essential cofactors for the normal functions of Myc in vivo.
Materials and Methods
Fly Lines and Clonal Analysis. Fly stocks were obtained from the
Bloomington StockCenter (IndianaUniversity), with the exception
of dmP0FM7 (30), pont5.1TM3, Ser (putative null allele, referred
to as pont in the text) (11), rept35TM3 (putative null allele, referred
to as rept in the text) (11), and dmPL35FM7 (31); the revertant lines
pontrev5 (used as control for pont5.1) and reptrev23 (used as control
for rept35) were generated in parallel with the null alleles pont5.1 and
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rept35 (with which they are isogenic) by precise excision of the
P-element insertions 022905 and P1706 (11), respectively.
Mitotic recombination was induced by using the FLPFRT
method (32). Females y w hs-flp122; rept06945 FRT2ATM6B were
crossed with males w;P(ubi-GFP.nls)3L1 P(ubi-GFP.nls)3L2
FRT2A or w;M(3)i55 hs-nGFP FRT(2A)TM6B (33). Females y w
hs-flp122;FRT82B pont5.1TM6B were crossed with males
w;FRT82B P(Ubi-GFP(S65T)nls)3R or w;FRT82B P(w,
c-myc)87E Sb63 M3(96C) (34). Larvae were heat-shocked at 37°C
for 1 h.
eydmPL35  y w dmPL35 tubFRT(dmyc-cDNA) FRT
GAL4Y; CyO, ey-Flp; eydmP0  w dmP0 tubFRT(dmyc-
cDNA)FRTGAL4 ey-FlpY; and eydm  y w dm
tubFRT(dmyc-cDNA)FRTGAL4 ey-FlpY. These differ-
ent genotypes express a rescuing dmyc cDNA (35) in all parts of the
body except for the head capsule, where Flp-mediated recombina-
tion eliminates the cDNA and allows expression of GAL4 instead.
Molecular Biology.The sequences for pGEX-dMyc (expressingGST
fused to amino acids 46–507 of dMyc), pCasper-hsp-HA-dMyc
[expressing three copies of the hemagglutinin (HA)-epitope tag
fused to full-length dMyc, H-dMyc], pUAS-HA-dMyc, pUAS-
AU1-Rept (expressing one copy of the AU1-epitope tag fused to
full-length Rept, A-Rept), and pUAS-9E10-Pont (expressing three
copies of the c-Myc epitope tag recognized bymonoclonal antibody
9E10, M-Pont) are available upon request.
Cell Culture and Transfection. Drosophila Schneider S2 cells were
grown at 25°C with Schneider medium (GIBCO) supplemented
with 10% heat-inactivated FCS and 100 units of penicillin
streptomycin (GIBCO). For stable transfection, 2 105 cells perml
were seeded in a medium flask. The day after, the medium was
removed and 10 g of pCasper-hsp-HA-dMyc and 4 g of pcP4
plasmids (36) were mixed with the Cellfectin reagent (GIBCO) in
serum-free medium and added to the cells. After 16 h, complete
medium was added, and pools of clones were selected for 2 weeks
in -amanitin (200 gml).
For transient transfections, 106 S2 cells per ml were plated in a
medium flask. One day later, 10 g of plasmid was transfected with
the Cellfectin reagent as described above. After 48 h, transfected
cells were subjected to a heat shock at 37°C for 1 h. After 2 h, cells
were harvested and lysates were prepared forWestern blot analysis.
Western Blot and Antibodies. Transfected S2 cells were washed in
PBS and lysed with a buffer containing 50mMHepes (pH 7.4), 150
mM NaCl, 1 mM EDTA, 0.5% Tween 20, and protease inhibitors.
Untransfected cells (5  107 cells per immunoprecipitation reac-
tion) were lysed in 50 mM Hepes, pH 7.5, containing 0.1% Triton
X-100, 250mMNaCl, and protease inhibitors. Fifty y w larvae were
homogenized and lysed (by shredding and sonication) in the same
buffer. The different lysates were subjected to sonication for 30 sec
on ice. After measurement of the protein concentration using the
Bio-Rad kit, lysates were immunoprecipitated by using specific
antibodies bound to Protein G-Sepharose (CL-4B, Amersham
Pharmacia Biotech). After immunoprecipitation, proteins were
separated by SDSPAGE, electrotransferred to a nitrocellulose
membrane, subjected to Western blot analysis with specific anti-
bodies, and visualized by enhanced chemiluminescence (ECL-Plus,
Amersham Pharmacia Biotech). Primary antibodies were rat an-
ti-HAmonoclonal antibody (Roche), mouse anti-AU1monoclonal
antibody (Covance, Richmond, CA), mouse anti-9E10 monoclonal
antibody (Covance), rabbit anti-9E10 polyclonal antiserum (Santa
Cruz Biotechnology), rabbit anti-Pont antiserum, guinea pig
anti-Rept antiserum, and nonimmune hybridoma supernatant for
control.
In Vitro Binding Assays. GST and GST–dMyc fusion proteins were
produced in bacteria (BL21) after induction with 0.1 mM isopropyl
-D-thiogalactoside for 5 h at 37°C. Cells were washed, resuspended
in STE buffer (100 mM NaCl10 mM TrisHCl, pH 8.01 mM
EDTA) and sonicated for 2 min on ice. After centrifugation, the
supernatants were incubated for 2 h with GST agarose beads
(Amersham Pharmacia Biotech). After extensive washes with STE
buffer, the GST proteins immobilized on the beads were separated
by SDSPAGE, and protein concentration was estimated by stain-
ing with Coomassie blue. Equal amount of GST and GST–dMyc
proteins were used for in vitro binding assays with the different cell
lysates. Binding was performed for 3 h at 4°C. After washing, the
bound material was resuspended in Laemmli sample buffer and
separated by SDSPAGE. The proteins were then visualized by
Western blot analysis.
Analysis of Adult Flies. Flies were reared under identical growth
condition andwere age-matched (3-day-oldmales) before weighing
with a precision scale (range 0.001–10 mg; Mettler ME30). To
determine ommatidial number, all ommatidia were counted from
scanning electron micrographs of the indicated number of eyes
from different animals. From the same photographs, the size of the
ommatidia was calculated by measuring the area of 20 ommatidia
located in the center of the eye using PHOTOSHOP (Adobe Systems,
San Jose, CA).
Results
Physical Interaction Between dMyc and PontRept. The interaction
with human Tip48 and Tip49 requires a short sequence element in
the N terminus of c-Myc called Myc Box 2. This functionally
important Myc Box 2 is conserved in dMyc (37), suggesting that
dMyc also has the potential to interact with Pont and Rept. Indeed,
we could observe a specific interaction between the N terminus of
dMyc and Pont or Rept in vitro (Fig. 4, which is published as
supporting information on the PNAS web site). To demonstrate
these interactions in cells, we coexpressed H-dMyc with M-Pont
andor A-Rept inDrosophila S2 cells and probed the lysates for the
existence of different protein complexes. As shown in Fig. 1 A and
B, all binary complexes could be observed. By using sequential
immunoprecipitation with a 9E10 antibody, elution with 9E10
peptide, and reprecipitation with anti-AU1 antibodies, we could
further demonstrate the existence of a ternary complex containing
H-dMyc, M-Pont, and A-Rept (Fig. 1C). Although these experi-
ments involved overexpression of the different proteins, we could
also detect the interaction of endogenous dMyc with endogenous
Pont or Rept (albeit more weakly), both from nontransfected S2
cells (Fig. 1D) and from third-instar larvae (Fig. 1E). These data
demonstrate that dMyc forms complexes with Pont and Rept
during normal development and that dMyc, Pont, and Rept can
form a ternary complex in Drosophila cells.
In the course of these experiments, we also noticed that, upon
strong overexpression, M-Pont can compete with A-Rept for
binding to dMyc in vitro and that theM-Pont:dMyc complex ismore
resistant to increasing NaCl concentrations than the A-Rept:dMyc
interaction (Fig. 4). These observations suggest that Pont can also
interact with dMyc in the absence of any bound Rept, although the
physiological significance of such a complex is currently unclear.
Function of pont and rept in Vivo. If the physical interaction with
Pont and Rept is important for dMyc function, we would expect
mutations in pont and rept to affect some of the processes that are
controlled by dMyc. However, currently there is only limited
information available concerning the function of Tip48 and Tip49
in metazoans: Flies carrying null mutations in pont or rept were
reported to die during early larval stages (11), whereas overexpres-
sion of putative dominant-negative versions of Tip49 in vertebrate
cells showed no defects (12, 17). A closer inspection of larvae
mutant for pont or rept further indicated that both genes might also
control growth and proliferation. Homozygous pont/ or rept/
larvae hatch at normal rates, showing that the zygotic product of
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neither gene is essential for embryogenesis. The mutant larvae live
for up to 7 days but grow only minimally in size (Fig. 2A); this
phenotype is similar to that of mutants in growth-controlling genes
(e.g., ref. 38) and to dmyc-null mutants (data not shown) (39). The
defects of pont/rept/ double mutants are very similar to the
single mutants, although these larvae don’t survive for longer than
5 days after egg deposition (Fig. 2A). Clones of pont/ or rept/
cells located within phenotypically wild-type imaginal discs grow
poorly, indicating that the observed defects are cell-autonomous.
Furthermore, these clones suffer from a phenomenon called “cell
competition”: When surrounded by phenotypically wild-type cells,
only a few small pont/ or rept/ clones survive at 72 h after the
induction of the clones (Fig. 2B), and none can be observed at 120 h
(data not shown). In contrast, when the cells surrounding the pont
or rept clones are growth-impaired (because they carry a dominantly
actingmutation in a gene coding for a ribosomal protein, a so-called
Minute mutation), the mutant clones thrive even at 120 h after
induction (Fig. 2C). Only few growth-controlling genes have been
demonstrated to suffer from cell competition, notably the Minute
loci and dmyc (30, 35, 40). This similarity of mutant phenotypes is
consistent with the possibility that dMyc, Pont, and Rept control
similar biological processes, as is the observation that all three genes
are expressed in very similar patterns during embryogenesis (dy-
namically regulated in the mesoderm and midgut) and larval
development (ubiquitously) (11, 30, 37). It should be noted that pont
and dmyc also show some differences in their mutant phenotypes.
Unlike dmyc mutant cells, pont/ cells are not smaller than
wild-type control cells, which is consistent with an involvement of
Pont in additional processes that are less affected by dmyc muta-
tions (e.g., in the control of cell-cycle progression).
Genetic Interaction of dmyc with pontrept in Vivo. The following
sections provide direct evidence for a genetic interaction between
dmyc and pont (and to a lesser extent rept) in vivo. Because the only
available pont and rept alleles are recessive lethal, we tested for
dominant interactions between pont andor rept and hypomorphic
dmyc alleles (called dm). The dmP0 allele is caused by a P-element
insertion in the dmyc promoter, which results in a reduced dmyc
expression; dmP0Y mutant males are characterized by a slightly
delayed development, thin bristles, and a weak reduction in body
size and viability (Table 1) (30). The severity of this phenotype is
dramatically enhanced when such dmP0Y mutant flies also carry
Fig. 1. Rept and Pont associate with dMyc in vivo. (A and B) M-Pont andor A-Rept were transiently transfected into S2 cells stably expressing H-dMyc (as
indicated). (Upper) Whole-cell lysates were immunoprecipitated with anti-AU1 antibodies for A-Rept (A) or anti-HA antibodies recognizing H-dMyc (B), followed
by immunoblotting with anti-tag antibodies to detect the proteins indicated on the right. (Lower) Immunoblots of whole-cell lysates to reveal the relative
expression levels of the indicated proteins. Positions of H-dMyc, M-Pont, and A-Rept, respectively, are indicated. The first lane in B Upper contains lysate of
nontransfected S2 cells. (C) M-Pont and A-Rept (lanes 1, 3, and 5) or M-Pont alone (lanes 2, 4, and 6) were transiently transfected into S2 cells stably expressing
H-dMyc. Cell lysates were incubated with 9E10 antibodies, and the immunoprecipitate was eluted with the 9E10 peptide (lanes 3 and 4). The eluate was then
reimmunoprecipitated with anti-AU1 antibodies (lane 5 and 6), and the immunoprecipitate was analyzed by immunoblotting. (D and E) S2 cell lysates (D) or
third-instar larval extracts (E) were incubated with anti-dMyc antibodies or control hybridoma supernatant. Immunoprecipitates were blotted with anti-dMyc
antibodies, anti-Pont, or anti-Rept antisera as indicated. The rightmost lanes show immunoblots of whole-cell lysates. Asterisks indicate the migration of the
endogenous proteins.
Fig. 2. Consequences of pont andor rept inactivation in vivo. (A) The sizes
of pont/, rept/, or rept/pont/ homozygous mutant larvae are shown
in comparison with those of wild-type larvae. Larvae of the indicated geno-
types were reared at 25°C and photographed at the indicated times after egg
deposition (in days). No rept pont double mutant larvae are alive after day 5.
(B and C) Analysis of mitotic pont (B) or rept (C) clones in third-instar imaginal
wing discs. Seventy-two hours after their induction, clones of cells with a
homozygous mutation for pont (B) or rept (data not shown) are consistently
smaller than their corresponding twin clones or even completely absent. (C) If
the clones are induced in animals heterozygous for a Minute mutation, their
growth is less disadvantaged and their size is still important 120 h after
induction in wing imaginal discs, as shown for clones with a homozygous
mutant for rept. (B Inset) A pont mutant clone is shown in higher magnifica-
tion (outlined with white dots in B, the corresponding twin spot is marked by
bright color and outlined with a solid line in B Inset). (C) The rept/ clones are
marked by the absence of color; the corresponding twin spots do not survive.






onemutant allele of pont: The viability drops from54% to 12%, and
the surviving flies take 2.4 days longer for their development and,
despite the extended period, ultimately eclose with a significantly
lower weight (Table 1). None of these defects are seen in control
crosses with dm flies. rept does not show any dominant interaction
with dmP0, and the pont rept double-mutant chromosome behaves
like a pont single mutant. In addition, dmP0Y; pont/ flies (but
none of the other genotypes) occasionally show notches in the
posterior wingmargin (data not shown). A closer inspection reveals
a significant decrease in the total wing area of dmP0Y; pont/ flies
compared with control, consistent with the functions of dMyc and
Pont in growth control. A large part of this size difference can be
attributed to a decrease in cell size (Table 3, which is published as
supporting information on the PNAS web site).
The Interaction of dmyc with pont and rept Is Essential for Eye
Development. The most striking manifestation of the genetic inter-
action between dmyc and pont is seen in the eye. Approximately
90% of dmP0Y; pont/ flies have small, irregularly shaped, and
slightly rough eyes. Penetrance and expressivity of the phenotype
are variable, but the anterior and ventral portions of the eye are
always most defective (Fig. 3C). Interestingly, the same defect can
also be observed in dmP0Y flies, albeit at a very low frequency (ref.
30 and unpublished data), but not in dmY flies that are het-
erozygous for pont. A quantitative analysis of adult eyes revealed a
significant reduction in ommatidial size in all dmP0Ymutant flies,
which is significantly exacerbated by heterozygosity for pont (Table
2). In addition, dmP0Y;pont/ eyes contain a reduced number of
ommatidia, indicating an essential role of the dmycpont interaction
for proliferation and growth during development.
Similar genetic interactions were also observed with a second
independent dmyc allele. eydmPL35 flies express the allele dmPL35
specifically in the eye (see Materials and Methods); these eyes are
onlymoderately affected in their appearance, but heterozygosity for
pont induces similar defects as described above (Table 2 and Fig. 5,
which is published as supporting information on the PNAS web
site). In addition, heterozygosity for rept also results in a weak
reduction of ommatidial number in eydmPL35eyes, providing
evidence that Rept might also act as a positive cofactor for dMyc.
As a further demonstration of specificity, the ectopic expression
of M-Pont in the eyes of eydmP0;pont/ flies (Materials and
Methods) fully rescued their defects (Table 2 and Fig. 5). Ectopic
expression of H-dMyc also rescued the morphology defect of
eydmP0;pont/ eyes but in addition produced gain-of-function
phenotypes, such as an increase in ommatidial size. These gain-of-
function effects are more pronounced in an eydmP0 or eydm
background (Table 2 andFig. 5), and they illustrate the documented
abilities of dMyc to promote growth and apoptosis (ref. 30 and L.
Montero and P.G., unpublished data).
In contrast, ectopic expression of A-Rept in eydmP0;pont/
flies enhanced penetrance and expressivity of their eye defects
(Table 2 and Fig. 5). Even when overexpressed in an eydmP0 or
an eydm background, A-Rept induced a rough eye appearance
and a slight reduction in ommatidial number (Table 2 and data not
shown); qualitatively similar results were obtained with two inde-
pendent transgenes in eydm flies. These results indicate that
A-Rept cannot substitute for Pont; instead, overexpression of
A-Rept seems to have a dominant-negative effect on ommatidial
number in an eydm;pont/ background and on ommatidial size
and number in an eydmP0;pont/ background. The basis for this
effect is not known, but it is possible that the imbalance of Rept to
Pont levels alters the composition of the multiprotein complexes
that mediate the functions of these two proteins and thereby
interferes with their function. It is further conceivable that endog-
enous Pont levels are relatively lower thanRept levels, which would
explainwhymild Pont overexpression does not cause any dominant-
negative effects andwhy heterozygosity for pont results in a stronger
genetic interaction with dmyc than heterozygosity for rept.
Cellular Basis of the Eye Defect in dmycpont Mutant Flies. A
comparison of control, dmP0Y and dmP0Y;pont/ third-instar
larval eye imaginal discs revealed no obvious defects in any of the
three genotypes with respect to overall shape and the pattern of
differentiating ommatidia (Fig. 6, which is published as supporting
information on the PNAS web site). However, all dmP0Y mutant
discs are significantly smaller than the control discs, and the pont
mutation (but not the rept mutation) further reduces their size;
these data are in excellent agreement with the effects of the
different genotypes on adult eye size (Table 2 and data not shown).
This size reduction presumably reflects a reduction in cell size in the
dmP0Y eye discs as compared with control discs. Heterozygosity
for pont further reduces this cell size and additionally reduces the
number of cells.
This effect on cell number could be caused by a decreased rate
of cell division andor an increased rate of apoptosis. The different
dmP0 genotypes contain similar numbers of mitotic cells (Fig. 6 and
data not shown), suggesting at most minor differences in cell-cycle
progression rates. However, a difference of only 5% in cell doubling
Fig. 3. Heterozygosity for pont or rept results in eye defects in hypomorphic
dmyc mutants. Representative scanning electron micrographs of adult eyes.
The genotypes shown are dmP0Y;  (A), dmP0Y; rept/ (B), dmP0Y;
pont/ (C),dmP0Y; rept/pont/ (D),eydmPL35Y; (E),eydmPL35Y;
rept/ (F), eydmPL35Y; pont/ (G), eydmPL35Y; rept/ pont/ (H). All
pictures are shown at the same magnification; anterior is to the left.
Table 1. Phenotypes of male y w and dmP0 mutant flies carrying








y wY; 98 (339) 10.3  0.6 (339) 863  56 (47)
y wY;pont 108 (281) 10.1  0.6 (281) 854  37 (27)
y wY;rept 92 (487) 10.0  0.5 (487) 828  44 (44)
y wY;rept pont 108 (363) 10.1  0.4 (363) 852  46 (33)
dmP0Y; 54 (287) 10.6  0.4 (287) 772  53 (46)
dmP0Y;pont 12 (55) 13.0  0.8 (55) 693  65 (21)
dmP0Y;rept 60 (301) 10.8  0.4 (301) 774  33 (29)
dmP0Y;rept pont 20 (81) 12.4  0.7 (81) 702  70 (25)
Viability is calculated as the percentage of the total of the expected
genotype. Development indicates the time from egg deposition until eclosion.
Values differing significantly (P  0.01) from their control (dmP0Y;) are
shown in bold. Standard deviations were calculated based on the total num-
ber of animals reported (indicated in parentheses). None of the y wY geno-
types differed significantly from y wY;. Note that relevant comparisons
can only be made within thedm(yw) and thedmP0flies, because the two lines
are not isogenic.
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time would be sufficient to explain the differences in cell number
between the genotype with the fewest cells (dmP0Y;pont/) and
the genotype with the most cells (y w), and such a difference would
have escaped our detection. In contrast, we did not find any
indications for an involvement of apoptosis in this phenotype,
because dmP0Y;pont/ and dmP0Y;pont/ discs do not show
any difference in the number of apoptotic cells; in addition,
expression of the viral caspase inhibitor p35 did not suppress the
morphological defects in eydmP0Y;pont/ eyes, nor did it affect
the number of ommatidia in these eyes (Fig. 7, which is published
as supporting information on the PNAS web site). Thus, we
consider a proliferation defect in dmP0Y;pont/ flies the most
likely explanation for the observed reduction of ommatidia in the
adult eyes.
Molecular Basis of the dMyc:Pont Interaction.An explanation for the
observed genetic interaction might be found in the genes whose
expression is controlled by dMyc:Pont complexes. To identify such
genes, we combinedmicroarrayswith anRNA interference (RNAi)
approach in S2 cells (see Supporting Materials and Methods, which
is published as supporting information on the PNAS web site). As
shown in Fig. 8, which is published as supporting information on the
PNASweb site, Pont andRept were found to control largely similar
genes, but there is surprisingly little overlap with the dMyc targets;
in particular, the genes activated by dMyc through canonical Myc
binding sites called E-boxes (7, 41) were not significantly affected
by RNAi against pont or rept. However, 11 genes were significantly
and in the same direction affected by RNAi against all three
proteins (8 up-regulated and 3 down-regulated) (Table 4, which is
published as supporting information on the PNAS web site).
Although we deem it unlikely that the misregulation of these genes
explains all of the observed defects in the dmY;pont/ mutants,
these genes may serve as examples for a larger class of genes that
are controlled by dMyc:Pont[:Rept] complexes. To confirm these
microarray results, we focused on onemodel target,midline fasciclin
(mfas). Mfas is involved in cell–cell adhesion; its levels are up-
regulated upon RNAi against dmyc, pont, or rept and rapidly
down-regulated upon dMyc overexpression in vivo (7). Quantitative
real-time PCR experiments showed that mfas levels are increased
in dmP0Y;pont/ double-mutant eye discs but not in single-
mutant or wild-type control discs, confirming that mfas is also a
target of dMyc:Pont complexes in vivo (Fig. 9, which is published as
supporting information on the PNAS web site). To determine
whether this effect is direct, we overexpressed H-dMyc in S2 cells
and carried out chromatin immunoprecipitation experiments. As
shown in Fig. 10 and Table 5, which are published as supporting
information on the PNASweb site, under these conditions H-dMyc
and endogenous Pont were found to be associated with a broad
region of the mfas promoter (which does not contain any recog-
nizable dMyc binding sites). These data suggest that dMyc:Pont
complexes bind to certain target promoters such asmfas through as
yet unidentified sequence motifs and mediate the transcriptional
repression of these genes. Impairment of this process (through a
combination of mutations in dmyc and pont) may then contribute
to a reduction in cellular growth and proliferation.
Discussion
This study provides evidence that Tip49Pont (and possibly Tip48
Rept) is an essential partner for Myc during normal development
and that it plays an important role in the control of Myc-dependent
transcription, growth, and proliferation. These conclusions are
supported by four lines of evidence. First, we show that dMyc
physically interacts with Rept and Pont in vitro, in cells, and in
larvae. Although ternary complexes containing dMyc, Rept, and
Pont can exist, we also provide evidence that dMyc can associate
with Pont in the absence of Rept, although it is unclear whether
such complexes lacking Rept have any physiological role in vivo.
The stronger genetic interaction with pont raises the possibility that






y wY; 735  18 (5) 246  5 (5) 1.86  0.26 (33)
y wY;pont 748  12 (5) 241  6 (5) 1.74  0.31 (51)
y wY;rept 727  12 (5) 244  5 (5) 1.73  0.19 (20)
y wY;rept pont 726  12 (5) 240  9 (5) nd
dmP0Y; 722  18 (5) 217  8 (5) 1.44  0.15 (33)
dmP0Y;pont 561  89 (7)* 157  16 (7)* 0.90  0.17 (51)
dmP0Y;rept 695  33 (5) 200  5 (5)** 1.51  0.24 (17)
dmP0Y;rept pont 532  82 (7)* 162  7 (7)* nd
eydmPL35Y; 685  35 (5) 194  10 (5) nd
eydmPL35Y;pont 591  39 (5)* 174  7 (5)** nd
eydmPL35Y;rept 637  10 (5)** 192  12 (5) nd
eydmPL35Y;rept pont 583  72 (5)** 156  9 (5)* nd
eydm; 729  10 (5) 244  8 (4) nd
eydm;UAS-H-dMyc 615  17 (5)* 329  27 (5)* nd
eydm;UAS-M-Pont 737  14 (5) 234  7 (5) nd
eydm;UAS-A-Rept 562  88 (5)* 226  13 (5) nd
eydmP0Y;UAS-lacZ 738  40 (10) 208  16 (10) nd
eydmP0Y;UAS-dMyc 615  90 (10)* 295  11 (10)* nd
eydmP0Y;UAS-M-Pont 754  37 (10) 216  7 (10) nd
eydmP0Y;UAS-A-Rept 535  108 (10)* 201  26 (10) nd
eydmP0Y;pont 514  34 (4) 169  19 (4) nd
eydmP0Y;pont UAS-H-dMyc 661  31 (3)* 312  4 (3)* nd
eydmP0Y;pont UAS-M-Pont 729  46 (3)* 227  5 (3)* nd
eydmP0Y;pont UAS-A-Rept 198  95 (3)* 167  20 (3) nd
Standard deviations were calculated based on the total number of animals (reported in parentheses). Values
differing significantly from their controls (lines 1, 5, 9, 13, 17, and 21 for samples 2–4, 6–8, 10– 12, 14–16, 18–20,
and 22–24, respectively) are marked with asterisks. *, P  0.01; **, P  0.05. The genotypes are explained in the
text. nd, not determined.






someof dMyc’s functionsmight bemediated by such complexes, but
the large degree of overlap between the targets of Pont and Rept
and the fact that in most biochemically purified complexes Tip48 is
accompanied by Tip49 suggest that most often these two proteins
function together.
Second, flies lacking zygotic pont or rept gene products arrest
their growth early during larval development, and mitotic clones
homozygous mutant for pont or rept suffer from the same type of
cell competition as do dmyc clones. These characteristics indicate a
requirement for PontRept for cellular proliferation and growth,
which is consistent with their functioning as cofactors for dMyc.
Third, pont shows a strong dominant genetic interaction with
dmyc. The causes for this interaction are likely to be defects in
cellular growth and proliferation. The control of growth is most
sensitive to variations in dMyc levels, because the moderate reduc-
tion of dMyc activity achieved in hypomorphic dmyc alleles already
results in a decrease in cell size but not cell numbers. Removal of
one copy of the pont gene exacerbates the growth defect and results
in a reduction of cell numbers. We did not find any indication that
apoptosis contributes to this reduction in cell number and, there-
fore, conclude that the cell number defects primarily reflect a
proliferation defect. It is important to stress that none of these
defects are seen in flies that are heterozygous for pont but wild-type
for dmyc, arguing strongly against purely additive effect of the pont
and dmyc mutations. Although we cannot strictly rule out the
possibility that Pont and dMyc act in parallel growth-controlling
pathways, such a dominant genetic interaction is indicative of close
functional connections. We have not observed a dominant effect of
the pont mutation on dMyc overexpression phenotypes (data not
shown), suggesting that Pont is not limiting in situations of mildly
increased dMyc levels. However, by using a vertebrate tissue culture
system (Rat1 cells), Wood and colleagues (12) demonstrated that
dominant-negative PontTip49 inhibits the ability of human c-Myc
to transform Rat1 fibroblasts in conjunction with activated Ras.
Overexpression of a dominant-negative protein mutant potentially
allows a stronger reduction of PontTip49 activity than can be
obtained in a heterozygous pont/ situation, and, thus, these
experiments further reinforce our observation of a genetic inter-
action between myc and pont.
Fourth, we have shown that the expression of several genes,
includingmfas, is increased upon down-regulation of dmyc, pont, or
rept in S2 cells and in dmycpont double-mutant eye imaginal discs
in vivo. Chromatin immunoprecipitation experiments further sug-
gest that mfas is a direct transcriptional target of Pont and dMyc.
Taken together, these data strongly argue that dMyc:Pont com-
plexes are essential regulators of proliferation and growth in vivo
and that they act at least partly by repressing the expression of target
genes, such as mfas. A similar repressive function has recently also
been found for Xenopus Pont and Rept (42); it was proposed that
the well characterized repression of the transactivator Miz1 by
c-Myc is mediated by Pont and Rept. Although it is tempting to
speculate that Drosophila Pont functions analogously, no fly ho-
molog of Miz1 has been identified. In addition, we currently do not
know which of the reported Pont-containing complexes (see the
Introduction) is responsible for the observed effect.
The function of Rept is less clear, because a rept mutant shows
only a weak interaction and only with one dmyc allele. In contrast,
overexpression of Rept strongly enhances the dmycpont mutant
phenotypes. This observation could indicate that Rept also acts as
antagonist of Pont and of dMyc:Pont complexes, analogously to
what has been proposed for the interaction betweenReptPont and
-Catenin (11). Alternatively, overexpression of Rept functions in
a dominant-negative fashion, possibly by titratingPont andor other
factors away from the multiprotein complexes in which they nor-
mally reside; in addition, Rept might be relatively more abundant
thanPont such that heterozygosity for rept does not show any effects
in most situations. Although we currently cannot rule out either
explanation, our identification of mfas as a common target for
dMyc, Pont, and Rept is more consistent with the latter possibility.
In conclusion, we have shown here that Pont, and possibly Rept,
assists dMyc in the control of cellular proliferation and growth
during normal development, presumably in part by repressing the
expression of certain target genes.
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